ABOUT | | |
| |
MULTIMEDIA
 |
ESONT
  Register your email address to receive alerts on new EuroTimes Issues
 
 
 


ESCRS EUROTIMES
MAY EDITION 2006

 From the Editors
Paul Rosen FRCS, FRCOphth

I would like to add my congratulations to Peter Barry and David Seal and their team
for the Endophthalmitis study and its definitive outcome published in the last edition of
Eurotimes.The study was a tremendous example of EU scientific collaboration...
 Special Focus
EURETINA general secretary speaks with EuroTimes about current treatment options for retinal disease
Success is improving with macular rotation procedures
A broad range of new agents are becoming available for treatment of choroidal neovascularisation due to agerelated macular degeneration
Current guidelines improve selection criteria for photodynamic therapy
Anecortave acetate showing good long-term results
Implantable telescope improves vision and quality of life in patients with advanced retinal disease
Belgian epidemiological study suggests dietary antioxidants
reduce risk of AMD
Variants of ABCA4 gene implicated in Stargardt’s disease
and retinitis pigmentosa
Research closes in on variants of
CFH gene as cause of AMD
Ruboxistaurin reduces vision loss from diabetic retinopathy in
randomised controlled trial
New agents showing promise in treatment of diabetic retinopathy
New treatments for diabetic retinopathy aim at a diverse
range of targets
ILM peeling reduces oedema but does not improve vision in patients with diabetic macular oedema
Triamcinolone helps relieve the symptoms caused by idiopathic juxtafoveolar telangiectasia in the short term
Large PMMA lenses offer advantages in patients undergoing vitreoretinal surgery
 
 Cataract and refractive
Multifocal IOL implantation useful for traumatic cataracts
Cataract patients prefer bandages to eyedrops in early postop
   
 Features